No abstract

Project ECHO® is an effective model to support primary healthcare providers treating HCV in DTAPs with similar rates of treatment uptake and SVR compared to patients in TLCs This article is protected by copyright. All rights reserved.

• Less than half of patients newly diagnosed with hepatitis C virus (HCV) in South Western Sydney, Australia, who are eligible for antiviral treatment received such treatment in the 12 months after diagnosis • Most general practitioners referred new patients with HCV to specialists, rather than starting patients on treatment themselves. A significant portion of HCV notifications did not receive adequate follow-up • New Public Health Unit notifications of HCV represent a clear target for investment, to improve continuity of care in the quest towards HCV elimination